U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07537413) titled 'Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia' on April 10.
Brief Summary: Aim: Demonstrate the equivalent efficacy and superior safety of Ceftriaxone 1 gram daily compared with Ceftriaxone 2 grams daily among hospitalized patients with community-acquired pneumonia who are not admitted to the intensive care unit.
Hypothesis: Among hospitalized patients outside of the intensive care unit with community-acquired pneumonia who are prescribed Ceftriaxone, a dosage of 1 gram daily will be associated with an equivalent rate of clinical cure and fewer adverse events than a dosage of 2 grams daily.
Study Start Date: Se...